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Longitudinal Relaxation Time Editing for Acetylcarnitine
Detection with 1H-MRS
Lucas Lindeboom,1,2* Yvonne M.H. Bruls,1,2y Petronella A. van Ewijk,1y
Matthijs K.C. Hesselink,2 Joachim E. Wildberger,1 Patrick Schrauwen,2 and
Vera B. Schrauwen-Hinderling1,2
Purpose: Acetylcarnitine formation is suggested to be crucial
in sustaining metabolic flexibility and glucose homeostasis.
Recently, we introduced a method to detect acetylcarnitine in
vivo with long TE 1H-MRS. Differences in T1 relaxation time
between lipids and acetylcarnitine can be exploited for addi-
tional lipid suppression in subjects with high myocellular lipid
levels.
Methods: Acquisition of spectra with an inversion recovery
sequence was alternated with standard signal acquisition to
suppress short T1 metabolite signals. A proof of principle
experiment was conducted in a lean subject and the new
approach was subsequently tested in four overweight/obese
subjects.
Results: Using the new T1 editing approach, lipid signals in
spectra of skeletal muscle can be (additionally) suppressed by
a factor of 10 using a TI of 900 ms. Combination of the long
TE protocol with the T1 editing resulted in a well-resolved ace-
tylcarnitine peak in the obese subjects.
Conclusion: The T1 editing approach suppresses short T1
metabolites and offers a new contrast in 1H-MRS. The
approach should be used in combination with a long TE in
subjects with high lipid contamination for accurate quantifica-
tion of the acetylcarnitine concentration. Magn Reson Med
77:505–510, 2017. VC 2016 International Society for Mag-
netic Resonance in Medicine




It has recently been proposed that the formation of acetyl-
carnitine is essential in maintaining metabolic flexibility
and glucose homeostasis (1–3). While high levels of
acetyl-CoA are known to inhibit pyruvate dehydrogenase
(PDH) complex activity, acetylcarnitine can be formed
from excess acetyl-CoA, in a reaction catalyzed by the
enzyme carnitine acetyltransferase (CrAT). As such, the
formation of acetylcarnitine can be viewed as a mitochon-
drial rescue mechanism to maintain low acetyl-CoA con-
centrations and to sustain aerobic pyruvate oxidation.
While research on acetylcarnitine has long been lim-
ited to biochemical analysis in muscle biopsies, it has
been shown that exercise-induced acetylcarnitine pro-
duction can be detected with short echo time (TE) proton
MR spectroscopy (1H-MRS), by analyzing pre- and post-
exercise difference spectra (4). Recently, we showed that
long TE spectroscopy promotes the detectability and
hence the quantification of the acetylcarnitine peak at
2.13 ppm due to TE-induced suppression of overlapping
lipid resonances, thereby enabling acetylcarnitine detec-
tion even in the absence of (exercise) interventions (5).
There is a relatively large difference in transversal
relaxation time (T2) between acetylcarnitine and lipid
resonances, causing the lipid signal to decay rapidly
with increasing TE. Increased suppression of the lipid
signal can be achieved by increasing TE, but this goes at
the expense of a lower signal-to-noise ratio (SNR) of the
acetylcarnitine signal. With an echo time of 350 ms, ace-
tylcarnitine is generally well detectable in a large
(48 mL) voxel in the upper leg (5). In obese subjects,
with high myocellular lipid levels, a residual lipid signal
can however still result in considerable contamination of
the acetylcarnitine resonance. This interferes with accu-
rate quantification of the acetylcarnitine concentration in
subjects with high lipid content in muscle, even more
so, as these subjects usually show low acetylcarnitine
concentrations. Alternative sources of contrast might
help to improve the suppression of lipid signals in these
cases.
An obvious alternative to T2 relaxation based contrast
is the use of spin-lattice relaxation time (T1) weighing. It
is known that the spin-lattice relaxation time of lipids is
relatively short (6,7) when compared with other metabo-
lites, such as total creatine (t-Cr) (6) but also acetylcarni-
tine. The precise T1 of acetylcarnitine has not been
reported, but we previously estimated the T1 of acetyl-
carnitine to be 2000 ms at 3T. This is also why we used
a relatively long TR of 6000 ms (5) in our previous
report, which was required to achieve sufficient SNR.
T1 contrast is traditionally achieved by using short TR.
As short TR results in suppression of signals with a long
T1 relaxation time (like acetylcarnitine), it is key to
reverse this traditional T1 contrast for acetylcarnitine
detection and for the concomitant suppression of the
lipid resonances. This can be realized by alternating
standard signal acquisition with an inversion recovery
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sequence with an intermediate inversion time (TI). Sub-
traction of both signals will result in destruction of short
T1 signals, while metabolites with a long T1 will be
retained. We here explored the use of this approach for




The approach used in this study is schematically
depicted in Figure 1. Essentially, in the first acquisition
an inversion recovery sequence is applied, using an adia-
batic hyperbolic secant pulse with a bandwidth of
5000 Hz to invert all spins and a Point Resolved Spec-
troscopy (PRESS) (8) sequence for volume selection. In a
second acquisition, the resonance frequency of the adia-
batic inversion pulse is set far off resonance (þ50 kHz),
leaving the magnetization on resonance unaffected and
effectively reducing the sequence to a normal PRESS
scheme.
We subtracted the noninverted spectrum from the
spectrum acquired with the inversion pulse, by alternat-
ing the phase of the receiver. As metabolites with a short
T1 relaxation time will recover faster to equilibrium dur-
ing the first acquisition, their contribution to the overall
signal is cancelled due to the subtraction scheme. Signal
yield will be highest for metabolites with a long T1. As
this approach is based on two separate acquisitions,
overall signal intensity will be lower when compared
with a nonedited acquisition within the same time
frame.
In this setting, optimal contrast between two metabo-
lites is dependent on their respective T1 relaxation times.
To illustrate this, we have plotted the relative signal
intensity (as %M0) as a function of the T1 relaxation
time of a metabolite for three different TI’s (TI¼ 300,
900, or 1500 ms, see Figure 2). The essence of our
approach, i.e., suppression of short T1 metabolites, is
observable directly in this plot. Signal intensity increases
with increasing T1. In the present case, we aim at near
complete suppression of the lipid signals in the region of
2.2-2.4 ppm. These lipid resonances have T1 relaxation
rates between 200 and 450 ms (7). For a TI of 900 ms, at
least 90% lipid suppression in this region is achieved,
which comes with an approximate 40% signal loss for
the acetylcarnitine resonance (or any resonance with a
FIG. 1. Schematic representation of the protocol to achieve T1
editing. Signal acquisition with an inversion recovery sequence,
using PRESS localization, is alternated with regular signal acquisi-
tion by setting the resonance frequency of the second adiabatic
inversion pulse far off resonance (þ50 kHz). The phase of the
receiver is alternated concomitantly to suppress short T1 metabo-
lites (in red). Long T1 metabolites are not relaxed to equilibrium
when using intermediate TI times, leading to incomplete subtrac-
tion of these metabolites and thus observable signals.
FIG. 2. Calculated relative signal intensity with the T1 editing approach as a function of T1 relaxation time, for three different TI times. Signal
intensity is given relative to equilibrium magnetization (M0). The lipid resonances are characterized by T1 relaxation times between 200 and
450 ms (gray bar), while we estimated the acetylcarnitine T1 to be 2000 ms (dotted vertical line). Relative signal intensity is plotted for a TI
of 300, 900, and 1500 ms. To ensure a suppression of the lipid signals by a factor of 10, a TI of 900 ms was used in the in vivo protocol.
Increasing TI will lead to increased suppression of short T1 metabolites, but decreased relative acetylcarnitine signal intensity. Coming with
the increased lipid suppression at a TI of 900 ms, the signal intensity of the acetylcarnitine will decay to be approximately 60% of M0.
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T1 of 2000 ms). Increasing TI will lead to an improved
suppression of short T1 metabolites, but this also comes
with a decreased signal intensity of the signal of interest.
Set-up and Subjects
To test the performance of this novel approach, measure-
ments were performed in a total of five subjects. In first
instance, the sequence was evaluated in one a healthy
subject [female, age 30 and body mass index BMI) 18 kg/
m2], in whom acetylcarnitine concentration was rela-
tively high and lipid content low. Next, the added value
of the novel approach above the earlier reported long TE
spectroscopy was tested in four overweight/obese subject
(male subjects, age 68 6 3 years and BMI 29 6 3 kg/m2)
with strong lipid signals masking the small acetylcarni-
tine peak. Experiments were approved by the institu-
tional medical ethics committee and written informed
consent was obtained from the subjects before these
experiments.
MRS Acquisition Protocol
All experiments were performed on a 3 Tesla (T) clinical
MR system (Achieva 3T-X, Philips Healthcare, Best, The
Netherlands) using a two-element flexible surface receive
coil. Subjects were positioned supine and feet first in the
magnet bore with the right foot constrained by two sand-
bags. The coil was placed over the vastus lateralis mus-
cle. T2-weighted turbo spin echo images were acquired,
consisting of three transversal slices and field of view
(FOV)¼250210 mm, slice thickness¼ 0.9 mm, repeti-
tion time/echo time (TR/TE)¼2000/100 ms and turbo
factor 20.
All spectra were acquired with a TR of 6000 ms. A
voxel of 40 mm  20 mm  60 mm was positioned in the
vastus lateralis muscle. Outer volume suppression using
three rest slabs was applied, to eliminate residual signals
of subcutaneous adipose tissue. An example of voxel
placement in the vastus lateralis muscle in one of the
obese subjects is shown in Figure 4A. Spectral band-
width was 2 kHz, number of acquired data points 2048,
number of averages (NSA) 20 and a four-step phase
cycling was applied. Shimming was performed with
FASTMAP-based shimming (9).
As proof of principle in the lean subject, a short TE
(40 ms) PRESS spectrum was acquired and compared
with acquisition with the T1 editing approach with a TI
of 900 ms and identical TE. Subsequently, a long TE
(350 ms) PRESS spectrum without T1 editing was com-
pared with the T1 editing approach using an intermedi-
ate and long TE (150 ms and 350 ms respectively). As
water has a T1 of approximately 1400 ms (6), we imple-
mented water suppression by selective excitations and
crusher gradients just before the PRESS excitation pulse.
The flip angle of the selective excitation pulse was
empirically set at 110 degrees.
In one of the obese subjects, also spectra with short
TE, with and without T1 editing, were acquired for com-
parison. In all four obese subjects, we compared the long
TE protocol with and without T1 editing (using TE of
150 and 350 ms). Additionally, in a separate experiment
in one of the obese subjects we intentionally placed the
voxel partially (approximately 10% of the total voxel vol-
ume) in the subcutaneous adipose tissue layer to maxi-
mize lipid contamination. We here tested the T1 editing
approach with a TE of 350 ms and compared this with a
long TE spectrum alone. We here omitted the rest slabs
for outer volume suppression.
RESULTS
Proof of Principle in Lean Subject
Using the T1 editing approach we were able to suppress
the lipid signals in the region from 0.9 to 2.5 ppm in the
short TE spectrum of the lean subject, as is visible in
Figure 3A. Upon application of the T1 editing approach,
the acetylcarnitine peak at 2.13 ppm is no longer masked
by lipids and appears as a single peak.
A comparison between the previously described long
TE protocol with and without T1 editing indicates that a
TI of 900 ms in combination with a TE of 150 ms results
in similar spectra, in terms of lipid suppression and ace-
tylcarnitine peak intensity, as illustrated in Figure 3B.
The combination of the long TE protocol and T1 editing
shows the additive effect of the two approaches on lipid
suppression. This results in a spectrum with the lowest
FIG. 3. Proof of principle experiment in a lean subject. Spectra
are acquired from the vastus lateralis muscle in a lean subject. A:
Acquisition of a regular PRESS spectrum with TE¼40 ms is com-
pared with the T1 editing approach with TI/TE¼900/40 ms. Lipid
signals are suppressed with T1 editing. The acetylcarnitine peak at
2.13 ppm is accentuated in the grey box. B: The long TE protocol
is compared with the T1 editing approach in the same subject.
The T1 editing approach (TI¼900 ms) with a TE of 150 ms leads
to comparable acetylcarnitine and lipid peak intensity, when com-
pared with the long TE (350 ms) protocol. Contrast between
EMCL and IMCL is slightly different, suggesting shorter T1 of the
IMCL signal. Combination of the long TE protocol with the T1 edit-
ing approach leads to almost complete suppression of the lipid
signals.
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remaining lipid signals, which comes with signal losses
of approximately 50% on the t-Cr (at 3.03 ppm) and 40%
on the acetylcarnitine peak.
Application in Overweight/Obese Subjects
In Figure 4B, the short TE spectra with and without T1
editing are shown for one of the obese subjects. In the
short TE spectrum alone, large lipid signals are visible.
When zooming in on the acetylcarnitine region it is clear
that these lipid signals are significantly reduced with the
T1 editing approach. However, residual lipid signals that
are still present make it difficult to accurately phase the
spectrum. As depicted for the same obese subject in Fig-
ure 4C, we found that for all four obese subjects, both
the long TE protocol and T1 editing approach with
(intermediate) TE of 150 ms, showed residual lipid peaks
overlapping with the acetylcarnitine resonance, thereby
hindering accurate quantification of this peak. Combina-
tion of the long TE protocol with the T1 editing approach
with a TI of 900 ms, resulted in enhanced suppression of
lipid signals, which in turn results in a well-resolved
acetylcarnitine peak in all subjects. In analogy with the
lean subject, we estimated that the T1 editing approach
comes with signal losses of approximately 50% for the t-
Cr (at 3.03 ppm) and 40% for the acetylcarnitine (when
assuming equal TE).
Suppression of Adipose Tissue Contamination
We have shown the spectra of the separate experiment,
where we intentionally placed a part of the voxel in the
subcutaneous adipose tissue, in Figure 5. In the long TE
spectrum the lipid signals from the adipose tissue clearly
contaminate the acetylcarnitine signal, which makes the
peak unobservable. The combination of the long TE pro-
tocol and the T1 editing approach however result in
complete suppression of the adipose tissue lipid signals,
thereby uncovering the acetylcarnitine peak. Signal
intensity of the acetylcarnitine peak was comparable
with the signal intensity for the acetylcarnitine peak
when the voxel was completely positioned inside the
muscle tissue, which illustrates further that adipose tis-
sue signals were completely suppressed in the acetylcar-
nitine region.
DISCUSSION AND CONCLUSIONS
We have shown here that differences in T1 relaxation
times of the overlapping resonances of lipids and acetyl-
carnitine, offer an alternative contrast mechanism to the
previously described T2 induced contrast (5) with long
TE. Signal suppression of short T1 metabolites, e.g., lip-
ids, can be achieved by subtraction of signals from an
inversion recovery of intermediate TI times (in the order
of 1000 ms) from signals from regular signal acquisition.
FIG. 4. Performance of the T1 editing approach in an obese subject. A: The voxel placement in the vastus lateralis muscle is shown.
Rest slabs for outer volume suppression are shown in blue. The chemical shift dependent voxel locations are shown for the lipid reso-
nance at 1.2 ppm (yellow box) and the t-Cr resonance at 3.03 ppm (white box). B: The results are depicted for short TE with and without
T1 editing (TE¼40 versus TI/TE¼900/40 ms). A closer look on the acetylcarnitine region shows that residual lipid signals are still pres-
ent with short TEþT1 editing. In C, T1 editing is combined with longer TE. The acetylcarnitine region of the spectrum is shown in more
detail on the right part of figure. A TE of 150 ms leads to insufficient suppression of the lipid signals. Identification and quantification of
the acetylcarnitine peak is also hampered in the long TE protocol alone (TE¼350 ms). A combination of the long TE protocol and T1
editing with TI 900 ms, leads to a well-resolved and well-defined acetylcarnitine peak. In panels B and C, the grey box is used to accen-
tuate the acetylcarnitine peaks at 2.13 ppm.
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While this approach offers T1 contrast in itself, combina-
tion of the long TE protocol with the T1 editing approach
offers improved lipid suppression and thus enhanced
acetylcarnitine visibility and more accurate quantifica-
tion in subjects with (very) high extra- and intramyocel-
lular lipid signals.
The detection of acetylcarnitine in vivo, with 1H-MRS
was first shown by subtraction of pre- and post-exercise
spectra (4), which limited its use to studies in which an
exercise intervention was performed. Recently, it was
suggested that acetylcarnitine formation may play a cru-
cial role in the capability of switching between basal fat
oxidation and insulin-stimulated glucose oxidation in
muscle (termed metabolic flexibility). Furthermore, the
capacity to form acetylcarnitine might be hampered in
insulin resistant subjects (1,2,5). To understand the role
of acetylcarnitine in more detail, it is crucial to develop
MR acquisition strategies that enable detection of this
metabolite at rest, without the need for an (exercise)
intervention. The relatively short T2 of lipids enables to
suppress these signals by prolonging the TE in a regular
PRESS sequence (5). For a TE of 350 ms, one can calcu-
late that approximately 98% of the lipid signal is sup-
pressed at 3T, which is sufficient for a large subset of
subjects. For obese subjects, with high myocellular lipid
content, the suppression might, however, not suffice for
accurate quantification of the acetylcarnitine signal. Aug-
menting lipid suppression by increasing TE above 350
ms is possible, but will unavoidably also lead to
unwanted loss of acetylcarnitine signal and hence long
acquisition times.
In a strive to optimize acetylcarnitine quantification
for subjects with high myocellular lipid content, we esti-
mated that differences in relative T1 relaxation times of
lipids and acetylcarnitine are even more pronounced
than differences in T2. These differences in T1 relaxation
times are exploited here. As in theory, the T1 editing
approach with short TE gives better contrast-to-noise
ratio, or improved lipid suppression at same acetylcarni-
tine signal intensities, when compared with the long TE
protocol, we anticipated the T1 editing approach to be
superior to the long TE protocol. In practice however,
system stability was limiting complete suppression of
the lipid signals due to subtraction artifacts with the T1
editing approach. Therefore, the single shot, long TE pro-
tocol, and subtraction-based T1 editing protocol per-
formed very similarly.
As an alternative strategy to use T1 differences
between acetylcarnitine and lipids, the conventional
inversion recovery sequence might also be used for nul-
ling of the lipid resonances that cover the acetylcarnitine
resonance. While this approach is more sensitive to var-
iations in T1 relaxation times, the absence of a subtrac-
tion scheme and a higher signal intensity (80% of M0
with IR with TI¼ 200 ms vs. 60% of M0 with the pro-
posed T1 editing approach) are advantageous. Initial
experiments using this approach, however, resulted in
spectra that could be not be accurately phased in the
acetylcarnitine region. This can be explained by the fact
that in 2.2–2.4 ppm region two separate lipid resonances
are contaminating the acetylcarnitine signal and these
lipid resonances are characterized by different T1 relaxa-
tion times (7). Nulling of the 2.2 ppm resonance on one
hand will lead to a negative signal component from the
2.4 ppm resonance. In contrast, with the proposed T1
editing approach the degree of suppression increases
with decreasing T1 relaxation times for a given TI. Nul-
ling of the 2.4 ppm resonance automatically also sup-
presses the shorter T1 resonance at 2.2 ppm.
For the lean subject, with low myocellular lipid sig-
nals, lipid suppression and accurate acetylcarnitine
quantification could already be achieved with the T1
editing approach with a TI of 900 ms and with short TE
of 40 ms. Importantly, the T1 editing approach can also
be combined with the long TE protocol to maximize the
suppression of lipid resonances. As both low acetylcarni-
tine concentrations and high lipid contamination are
characteristic for obese subjects and patients with type 2
FIG. 5. Suppression of subcutane-
ous adipose tissue contamination
with T1 editing. Intentional place-
ment of part of the voxel in the sub-
cutaneous adipose tissue around
the vastus lateralis muscle, leads to
large lipid signals, even with
TE¼350 ms. The acetylcarnitine
peak cannot be resolved in this
case. Lipid signals are suppressed
by the use of the T1 editing
approach (TI¼900 ms), as is shown
in more detail in the zoom view of
the region of the acetylcarnitine res-
onance (1.5–3 ppm region).
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diabetes (T2DM), the use of the T1 editing approach in
combination with the long TE protocol leads to
enhanced suppression of the lipid signals covering the
(small) acetylcarnitine peak in these subjects, enabling
more accurate quantification of this peak. The power of
this approach is also illustrated by a separate experiment
in one of the obese subjects where we intentionally
placed the voxel partially in the subcutaneous adipose
tissue layer to maximize lipid contamination. The T1
editing approach with long TE (350 ms) still resulted in
complete suppression of the adipose tissue lipid signals
and resulted in a well resolved acetylcarnitine peak.
This peak was completely covered by lipid resonances
in the long TE protocol alone.
Of course, not only the lipid and acetylcarnitine signal
intensities are affected by the proposed T1 editing
approach. As can be deduced from the spectra acquired
with this approach, the t-Cr peak is also well preserved
in the spectra. This peak can be used as an internal refer-
ence for absolute quantification of acetylcarnitine. In our
experiments we estimated the signal losses on approxi-
mately 50% for t-Cr and 40% for acetylcarnitine, which
is well in line with the theoretically estimated signal
loss (based on a T1 of 1100 (6) ms for t-Cr and 2000 ms
for acetylcarnitine, see also Figure 2). Thus, for absolute
quantification, additional corrections should be applied
to compensate for the T1 induced signal losses on all the
metabolites of interest. Accurate determination of the T1
relaxation times of t-Cr and acetylcarnitine is warranted
in the target patient group.
However, as acetylcarnitine concentrations are chang-
ing rapidly, care has to be taken to account for these
fluctuations during the determination of relaxation
times. Also, changes in T1 and T2 relaxation times with
for example disease or after exercise, might induce quan-
tifications errors or bias when comparing different
groups. While exact data on the T1 relaxation time of
acetylcarnitine are lacking, it can be estimated that when
the proposed T1 editing approach is used, a T1 difference
of -350 ms (e.g., T1¼1650 ms instead of 2000 ms) would
lead to an underestimation of 10% of the acetylcarnitine
concentration. A T1 difference ofþ500 ms (e.g.,
T1¼ 2500 ms instead of 2000 ms) would lead to an over-
estimation of around 10%. Thus, although the approach
leads to heavy T1 weighing, the intrinsic long T1 of ace-
tylcarnitine reduces the risk for quantification errors
with changing T1 rates. For T2, either a positive or nega-
tive shift of 20 ms would lead to under- or overestima-
tion of 10%. Importantly, we have previously shown
that the T2 relaxation time for acetylcarnitine is similar
for lean and obese subjects (5). Furthermore, T2 of acetyl-
carnitine did not differ pre- and postexercise in lean sub-
jects (data not published).
Overall, we conclude that the T1 editing approach
enhances the visibility of overlapping metabolites with a
long T1. Using T1 editing in addition to the long TE proto-
col is a feasible strategy to improve detection of the ace-
tylcarnitine peak in subjects with high lipid signals in
skeletal muscle, although signal intensity is reduced by
approximately 40% when compared with the long TE pro-
tocol alone. The combination of T1 editing with long TE
optimally suppresses lipid signals and achieves near-
complete cancellation of lipid signals, even in obese sub-
jects where myocellular lipids are abundant. Importantly,
as acetylcarnitine metabolism seems to be disturbed in
obesity and T2DM, these patients are the most interesting
population to study in that respect. The proposed tech-
nique will hence be essential to advance the study on the
significance of carnitine metabolism in obesity and
T2DM. The application of the T1 editing approach in
other tissues, and in identifying metabolites that have
been uncovered to date, requires future evaluation.
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